Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?
about
Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@ast
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@en
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@nl
type
label
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@ast
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@en
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@nl
prefLabel
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@ast
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@en
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@nl
P2093
P2860
P356
P1433
P1476
Changes in prostaglandin E2 in ...... : is there a clinical benefit?
@en
P2093
Axel Hegele
Carsten Frohme
Jörg Hänze
Peter Olbert
Rainer Hofmann
Sonja Knippschild
P2860
P2888
P356
10.1186/1471-2490-14-85
P577
2014-11-04T00:00:00Z
P5875
P6179
1008837070